Evommune, Inc.

Evommune is a clinical-stage biotechnology company dedicated to developing innovative therapies targeting immune-mediated inflammatory diseases. By leveraging deep immunology expertise and a distinctive pipeline, we aim to address the fundamental causes of these conditions and provide effective solutions for patients with significant unmet medical needs.